Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine vs desvenlafaxine in adults with major depressive disorder and partial SSRI response
2019-002704-41Phase 4Completed
- Sponsor
- Lundbeck
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing vortioxetine arm with desvenlafaxine arm (2 arms). Primary endpoint: Change in MADRS total score. Started Jan 2020; status: completed.
02
Drugs
vortioxetinedesvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2019-002704-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002704-41.